This webpage contains legacy information. The product is either no longer available from the supplier or has been delisted at Labome.
product summary
company name : 
EMD Millipore
other brands : 
Oncogene Research Products, Calbiochem, Novagen, Merck, Upstate Biotechnology, Chemicon, LINCO, Novabiochem, Guava
product type : 
antibody
product name : 
PhosphoDetect™ Anti-GSK3beta (pSer9) Mouse mAb (2D3)
catalog : 
361527-1SET
quantity : 
1 set
clonality : 
monoclonal
host : 
mouse
conjugate : 
nonconjugated
antigen modification : 
phosphorylated
reactivity : 
human, mouse, rat
application : 
western blot, ELISA
product information
Catalog Number : 
361527-1SET
Category : 
Antibodies
Subcategory : 
Cell Signaling
Product Name : 
PhosphoDetect™ Anti-GSK3beta (pSer9) Mouse mAb (2D3)
Product Type : 
Antibodies
Clonality : 
Monoclonal
Gene ID : 
2932 (Hu), 56637 (Ms), 84027 (Rt)
Host Name : 
M
Clone : 
2D3
Conjugate : 
Purified
Isotype : 
IgG1
Product Description : 
PhosphoDetect™ Anti-GSK3beta (pSer9) Mouse mAb (2D3)
Cross Reactivity : 
Human, Mouse
ALT Names : 
7330414F15Rik, 8430431H08Rik, C86142, GSK-3, GSK-3BETA, Gsk-beta, Tpk1, glycogen synthase kinase 3 beta
Immunogen : 
a synthetic phosphopeptide corresponding to amino acids surrounding the Ser 9 phosphorylation site of human glycogen synthase kinase 3beta
Specificity : 
Recognizes the ~46 kDa GS-K3beta phosphorylated at Ser 9 .
Package Size : 
1 set
Uses : 
ELISA, WB
Storage : 
Reconstitute the positive control lysate with 200 ul H 2 O. Following complete solubilization, add 200 ul SDS-PAGE sample buffer and incubate at 90°C for 5 min.
company information
EMD Millipore
290 Concord Road
Billerica, Massachusetts 01821
Billerica, Massachusetts 01821
bioscienceshelp@emdchemical.com
https://www.emdmillipore.com888-854-3417
headquarters: United States
EMD Millipore is the Life Science division of Merck KGaA of Darmstadt, Germany
Hundreds of New Antibodies in the areas of: 
View all the new antibodies at www.emdmillipore.com.
Hundreds of New Antibodies in the areas of:
| 
 | 
 | 
questions and comments
